ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
1 hedge funds and large institutions have $3K invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0.02% more ownership
Funds ownership: 0% → 0.02% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.37K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $3K | +$3.37K | +154 | New |
|
IWFL Hedge Fund Activity: Q2 2022 in Review
1 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q2 2022, worth a combined $3K.
Buyers outnumbered sellers: 1 fund opened new IWFL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.37K.
- 1 institutional investor held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q2 2022, up from 0 in Q1 2022.
- Funds reported $3K of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q2 2022.
- 1 fund opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN buyer in Q2 2022 was UBS Group, an estimated $3.37K added.
Based on aggregated 13F filings for Q2 2022.